| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
KBIO COMPANY Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩270.00 |
| 52 Week High | ₩591.00 |
| 52 Week Low | ₩225.00 |
| Beta | -0.15 |
| 1 Month Change | -21.74% |
| 3 Month Change | 14.41% |
| 1 Year Change | -46.00% |
| 3 Year Change | -80.43% |
| 5 Year Change | -91.74% |
| Change since IPO | -99.71% |
Recent News & Updates
Shareholder Returns
| A038530 | KR Semiconductor | KR Market | |
|---|---|---|---|
| 7D | -2.5% | 0.0003% | 3.4% |
| 1Y | -46.0% | 77.9% | 7.1% |
Return vs Industry: A038530 underperformed the KR Semiconductor industry which returned 77.9% over the past year.
Return vs Market: A038530 underperformed the KR Market which returned 7.1% over the past year.
Price Volatility
| A038530 volatility | |
|---|---|
| A038530 Average Weekly Movement | 12.7% |
| Semiconductor Industry Average Movement | 8.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A038530's share price has been volatile over the past 3 months.
Volatility Over Time: A038530's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 36 | Jong-Ju Lee | www.gold-pacific.com |
KBIO COMPANY Inc. engages in the bio distribution business. The company supplies experimental equipment and various reagents to general hospitals, universities, research institutes, etc.; and engages in distribution, bidding, equipment rental, and other business. It serves through online and offline stores.
KBIO COMPANY Inc. Fundamentals Summary
| A038530 fundamental statistics | |
|---|---|
| Market cap | ₩31.18b |
| Earnings (TTM) | -₩11.82b |
| Revenue (TTM) | ₩27.32b |
1.1x
P/S Ratio-2.6x
P/E RatioIs A038530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A038530 income statement (TTM) | |
|---|---|
| Revenue | ₩27.32b |
| Cost of Revenue | ₩23.73b |
| Gross Profit | ₩3.59b |
| Other Expenses | ₩15.41b |
| Earnings | -₩11.82b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -102.32 |
| Gross Margin | 13.16% |
| Net Profit Margin | -43.25% |
| Debt/Equity Ratio | 0% |
How did A038530 perform over the long term?
See historical performance and comparison